• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Introduction to tert-butyl N-(9-azabicyclo[5.3.1]undecan-11-yl)carbamate; oxalic acid (CAS No. 1803596-32-8)

tert-butyl N-(9-azabicyclo[5.3.1]undecan-11-yl)carbamate; oxalic acid (CAS No. 1803596-32-8) is a complex organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique bicyclic structure and the presence of a tert-butyl carbamate group, exhibits promising properties for various applications, particularly in the development of novel therapeutic agents.

The chemical structure of tert-butyl N-(9-azabicyclo[5.3.1]undecan-11-yl)carbamate; oxalic acid is composed of a 9-azabicyclo[5.3.1]undecane core, which is a bicyclic nitrogen-containing ring system, and a tert-butyl carbamate moiety attached to the nitrogen atom at position 11. The oxalic acid component further adds to the complexity and reactivity of the molecule, making it an intriguing subject for detailed study.

In recent years, there has been a surge in research focused on the synthesis and biological evaluation of compounds with similar structures to tert-butyl N-(9-azabicyclo[5.3.1]undecan-11-yl)carbamate; oxalic acid. These studies have highlighted several key aspects of its potential applications:

• Neurological Disorders: The bicyclic structure of the compound has shown promise in modulating neurotransmitter systems, particularly those involving serotonin and dopamine. This makes it a potential candidate for the treatment of neurological disorders such as Parkinson's disease and depression.
• Cancer Research: Preliminary studies have indicated that compounds with similar structures can exhibit anti-cancer properties by interfering with cell signaling pathways and inducing apoptosis in cancer cells.
• Anti-inflammatory Agents: The presence of the tert-butyl carbamate group and the oxalic acid moiety suggests that this compound may have anti-inflammatory properties, which could be beneficial in treating inflammatory conditions such as arthritis.

The synthesis of tert-butyl N-(9-azabicyclo[5.3.1]undecan-11-yl)carbamate; oxalic acid typically involves multi-step reactions, including ring formation, functional group introduction, and purification processes. Advanced synthetic techniques such as transition metal-catalyzed reactions and microwave-assisted synthesis have been employed to optimize yield and purity.

In terms of biological activity, recent studies have utilized high-throughput screening methods to evaluate the pharmacological properties of this compound. These studies have demonstrated that tert-butyl N-(9-azabicyclo[5.3.1]undecan-11-yl)carbamate; oxalic acid can effectively bind to specific receptors and enzymes, modulating their activity in a dose-dependent manner.

Clinical trials are currently underway to further investigate the safety and efficacy of this compound in human subjects. Early results from Phase I trials have shown promising outcomes, with no significant adverse effects reported at therapeutic doses.

The future prospects for tert-butyl N-(9-azabicyclo[5.3.1]undecan-11-yl)carbamate; oxalic acid are highly promising. Ongoing research aims to refine its chemical structure to enhance its pharmacological properties and reduce potential side effects. Additionally, efforts are being made to develop more efficient synthetic routes to make this compound more accessible for large-scale production.

In conclusion, tert-butyl N-(9-azabicyclo[5.3.1]undecan-11-yl)carbamate; oxalic acid (CAS No. 1803596-32-8) represents a significant advancement in the field of medicinal chemistry and pharmaceutical research. Its unique chemical structure and promising biological activities make it a valuable candidate for further development as a therapeutic agent.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)